Info: ACS Cancer Prevention Study-3
This is from the American Cancer Society:
Utah residents have the opportunity to participate in the third installment of a historic research study that has the potential to change the face of cancer for future generations. The American Cancer Society aims to recruit 1,200 additional study participants by Oct. 31 in the Salt Lake area, for its Cancer Prevention Study-3 (CPS-3). The organization will continue to recruit volunteers until the actual enrollment dates at various partner host sites throughout Salt Lake, Davis and Weber Counties, from Nov. 13-17.
Here are the 10 host sites to participate in the study:
University of Utah Medical Center 50 Medical Drive, Salt Lake City, Tuesday, Nov. 13, 9 a.m.-12:30 p.m. and Wednesday, Nov.14, 4 p.m.-7:30 p.m.
Intermountain Medical Center 5160 S. Cottonwood Street, Murray, Tuesday, Nov. 13, 10 a.m.-1:30 p.m. and Wednesday, Nov. 14, 9 a.m.-12:30 p.m.
Questar – Employees and Families only 333 South State Street, Salt Lake City, Tuesday, Nov. 13, 7 a.m.-12:30 p.m.
Questar – Employees and Families only 1140 W. 200 S., Salt Lake City, Wednesday, Nov.14, 7 a.m.-10:30 a.m.
Davis Hospital 1600 West Antelope Drive, Layton, Wednesday, Nov. 14, 3 p.m.-6:30 p.m. and Friday, Nov. 16, 7 a.m.-10:30 a.m.
Huntsman Cancer Hospital 2000 Circle of Hope Drive, Salt Lake City, Thursday, Nov. 15, 9 a.m.-2:30 p.m.
The Church of Jesus Christ of Latter Day Saints Conference Center 60 West North Temple, Salt Lake City, Thursday, Nov. 15, 10 a.m.-1:30 p.m. and Friday, Nov. 16, 10 a.m.-1:30 p.m.
Walgreens 5353 South 960 East, Salt Lake City, Thursday, Nov. 15, 10 a.m.-1:30 p.m. and Friday, Nov. 16, 10 a.m.-1:30 p.m.
McKay-Dee Hospital 4401 Harrison Boulevard, Ogden, Friday, Nov. 16, 9 a.m.-12:30 p.m.
American Cancer Society 941 East 3300 South, Salt Lake City, Saturday, Nov. 17, 9 a.m.-12:30 p.m.
CPS-3 aims to enroll a diverse population of men and women between the ages of 30-65 across the United States and Puerto Rico, to help researchers better understand the lifestyle, environmental, and genetic factors that cause or prevent cancer. Researchers will use the data from CPS-3 to build on evidence from a series of American Cancer Society studies that began in the 1950s, which have collectively involved millions of volunteer participants. Data from past studies has helped establish monumental findings, including the link between cigarette smoking and lung cancer.
“My mom is a two-time cancer survivor and I’m doing all I can to make sure my children don’t have to say that; I really believe CPS-3 is part of the answer,” stated one study participant.
To participate in the study, individuals will spend between 20-30 minutes at a local enrollment site to complete a brief survey, have their waist circumference measured and give a small blood sample. At home, individuals will complete a comprehensive survey packet that asks for information on lifestyle, behavioral, and other factors related to their health. Participants should expect a follow-up survey to update information every few years.
“CPS-3 will help us better understand what factors cause cancer, and once we know that, we can be better equipped to prevent cancer,” said Alpa V. Patel, Ph.D., principal investigator of CPS-3. “The study holds the best hope of identifying new and emerging cancer risks, but we can only do this if members of the community are willing to become involved.”
The Hammond-Horn Study and previous Cancer Prevention Studies (CPS-I, and CPS-II) have played a major role in understanding cancer prevention and risk, and have contributed significantly to the scientific basis and development of public health guidelines and recommendations. Those studies confirmed the link between cigarette smoking and lung cancer, demonstrated the link between larger waist size and increased death rates from cancer and other causes, and showed the considerable impact of air pollution on heart and lung conditions.
For more information or to learn how to become a CPS-3 Community Champion, visit cps3utah.org, or call 1-888-604-5888.